scholarly journals A multicenter, phase II study of R-THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, indolent B-cell lymphoma

2021 ◽  
Author(s):  
Kazunori Ohnishi ◽  
Ken Ohmachi ◽  
Kiyoshi Ando ◽  
Kazuhito Yamamoto ◽  
Tatsuya Ito ◽  
...  
Keyword(s):  
Elderly Patients ◽  
B Cell ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Advanced Stage ◽  
Newly Diagnosed ◽  
Multicenter Phase

scholarly journals Safety of chidamide plus rituximab in elderly patients with relapsed or refractory B-cell lymphoma in China: a multicenter, single-arm, phase II study

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Xinrui Chen ◽  
Huaqing Wang ◽  
Xiuhua Sun ◽  
Liping Su ◽  
Fengting Liu ◽  
...  
Keyword(s):  
Elderly Patients ◽  
B Cell ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
B Cell Lymphoma

Japanese multicenter phase II study of CHOP followed by radiotherapy (RT) in stage I-II1 diffuse large B-cell lymphoma (DLBCL) of the stomach

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 6527-6527
Author(s):  
S. Ishikura ◽  
K. Tobinai ◽  
A. Ohtsu ◽  
S. Nakamura ◽  
T. Yoshino ◽  
...  
Keyword(s):  
B Cell ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Stage I ◽  
Large B Cell Lymphoma ◽  
Multicenter Phase ◽  
Large B Cell

Phase II study of Gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial

2009 ◽  
Vol 28 (2) ◽  
pp. 171-177 ◽  
Author(s):  
Sung Yong Oh ◽  
Won Seog Kim ◽  
Dae Ho Lee ◽  
Seok Jin Kim ◽  
Sung Hyun Kim ◽  
...  
Keyword(s):  
B Cell ◽  
Phase Ii ◽  
Marginal Zone ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Advanced Stage
Sign in / Sign up

Export Citation Format

Share Document